Literature DB >> 23852030

Synthetic and editing mechanisms of aminoacyl-tRNA synthetases.

John J Perona1, Ita Gruic-Sovulj.   

Abstract

Aminoacyl-tRNA synthetases (aaRS) ensure the faithful transmission of genetic information in all living cells. The 24 known aaRS families are divided into 2 structurally distinct classes (class I and class II), each featuring a catalytic domain with a common fold that binds ATP, amino acid, and the 3'-terminus of tRNA. In a common two-step reaction, each aaRS first uses the energy stored in ATP to synthesize an activated aminoacyl adenylate intermediate. In the second step, either the 2'- or 3'-hydroxyl oxygen atom of the 3'-A76 tRNA nucleotide functions as a nucleophile in synthesis of aminoacyl-tRNA. Ten of the 24 aaRS families are unable to distinguish cognate from noncognate amino acids in the synthetic reactions alone. These enzymes possess additional editing activities for hydrolysis of misactivated amino acids and misacylated tRNAs, with clearance of the latter species accomplished in spatially separate post-transfer editing domains. A distinct class of trans-acting proteins that are homologous to class II editing domains also perform hydrolytic editing of some misacylated tRNAs. Here we review essential themes in catalysis with a view toward integrating the kinetic, stereochemical, and structural mechanisms of the enzymes. Although the aaRS have now been the subject of investigation for many decades, it will be seen that a significant number of questions regarding fundamental catalytic functioning still remain unresolved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23852030     DOI: 10.1007/128_2013_456

Source DB:  PubMed          Journal:  Top Curr Chem        ISSN: 0340-1022


  51 in total

1.  Comparison of histidine recognition in human and trypanosomatid histidyl-tRNA synthetases.

Authors:  Cho Yeow Koh; Allan B Wetzel; Will J de van der Schueren; Wim G J Hol
Journal:  Biochimie       Date:  2014-08-20       Impact factor: 4.079

2.  The tRNA A76 Hydroxyl Groups Control Partitioning of the tRNA-dependent Pre- and Post-transfer Editing Pathways in Class I tRNA Synthetase.

Authors:  Nevena Cvetesic; Mirna Bilus; Ita Gruic-Sovulj
Journal:  J Biol Chem       Date:  2015-04-14       Impact factor: 5.157

Review 3.  The Mechanisms of Substrate Selection, Catalysis, and Translocation by the Elongating RNA Polymerase.

Authors:  Georgiy A Belogurov; Irina Artsimovitch
Journal:  J Mol Biol       Date:  2019-05-31       Impact factor: 5.469

4.  Error-prone protein synthesis in parasites with the smallest eukaryotic genome.

Authors:  Sergey V Melnikov; Keith D Rivera; Denis Ostapenko; Arthur Makarenko; Neil D Sanscrainte; James J Becnel; Mark J Solomon; Catherine Texier; Darryl J Pappin; Dieter Söll
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-18       Impact factor: 11.205

Review 5.  Progress and challenges in aminoacyl-tRNA synthetase-based therapeutics.

Authors:  Christopher S Francklyn; Patrick Mullen
Journal:  J Biol Chem       Date:  2019-01-22       Impact factor: 5.157

Review 6.  Function and origin of mistranslation in distinct cellular contexts.

Authors:  Michael H Schwartz; Tao Pan
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-01-11       Impact factor: 8.250

Review 7.  Urzymology: experimental access to a key transition in the appearance of enzymes.

Authors:  Charles W Carter
Journal:  J Biol Chem       Date:  2014-09-10       Impact factor: 5.157

Review 8.  Coding of Class I and II Aminoacyl-tRNA Synthetases.

Authors:  Charles W Carter
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

9.  Homologous trans-editing factors with broad tRNA specificity prevent mistranslation caused by serine/threonine misactivation.

Authors:  Ziwei Liu; Oscar Vargas-Rodriguez; Yuki Goto; Eva Maria Novoa; Lluís Ribas de Pouplana; Hiroaki Suga; Karin Musier-Forsyth
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

10.  The physiological target for LeuRS translational quality control is norvaline.

Authors:  Nevena Cvetesic; Andrés Palencia; Ivan Halasz; Stephen Cusack; Ita Gruic-Sovulj
Journal:  EMBO J       Date:  2014-06-16       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.